rs11765015
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003040.4(SLC4A2):c.2536-294G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 152,050 control chromosomes in the GnomAD database, including 5,766 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 5766 hom., cov: 32)
Consequence
SLC4A2
NM_003040.4 intron
NM_003040.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.06
Publications
15 publications found
Genes affected
SLC4A2 (HGNC:11028): (solute carrier family 4 member 2) This gene encodes a member of the anion exchanger family of membrane transport proteins. The encoded protein regulates intracellular pH, biliary bicarbonate secretion, and chloride uptake. Reduced expression of this gene may be associated with primary biliary cirrhosis (PBC) in human patients, while differential expression of this gene may be associated with malignant hepatocellular carcinoma, colon and gastric cancers. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.388 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC4A2 | NM_003040.4 | c.2536-294G>A | intron_variant | Intron 16 of 22 | ENST00000413384.7 | NP_003031.3 | ||
| SLC4A2 | NM_001199692.3 | c.2536-294G>A | intron_variant | Intron 16 of 22 | NP_001186621.1 | |||
| SLC4A2 | NM_001199693.1 | c.2509-294G>A | intron_variant | Intron 15 of 21 | NP_001186622.1 | |||
| SLC4A2 | NM_001199694.2 | c.2494-294G>A | intron_variant | Intron 15 of 21 | NP_001186623.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.267 AC: 40549AN: 151932Hom.: 5754 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40549
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.267 AC: 40579AN: 152050Hom.: 5766 Cov.: 32 AF XY: 0.272 AC XY: 20199AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
40579
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
20199
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
8387
AN:
41490
American (AMR)
AF:
AC:
6045
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1111
AN:
3468
East Asian (EAS)
AF:
AC:
2036
AN:
5150
South Asian (SAS)
AF:
AC:
1262
AN:
4826
European-Finnish (FIN)
AF:
AC:
2988
AN:
10566
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17669
AN:
67974
Other (OTH)
AF:
AC:
589
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1466
2932
4398
5864
7330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1147
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.